But there is no established treatment for NAFLD besides weight loss and treatment of metabolic syndrome.
但是除了减轻体重和治疗代谢综合征，还没有确定的治疗NAFLD的方法。
NAFLD has very few symptoms, and one of the earliest indicators that there's a problem is an elevated level of liver enzymes.
非酒精性脂肪肝几乎没有任何征兆，最早的征兆之一就是肝酵素升高。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease among people who don't drink alcohol, and your risk for developing the condition increases along with your weight.
非酒精性脂肪肝病(NAFLD)是一种常见的慢性肝病，患者大都不喝酒，并且发病的概率与患者的体重成正比。
The NAFLD is probably one of components of metabolic syndrome.
NAFLD可能是代谢综合征的一个组成部分。
Conclusion: Transient elastography is accurate in most NAFLD patients.
结论：瞬时弹性超声对大多数NAFLD患者来说是准确的。
NAFLD, metabolic syndrome (MS) and insulin resistance are closely related.
NAFLD与代谢综合征(MS)和胰岛素抵抗的关系密切。
Hepatology Digest: For NAFLD, weigh loss therapy is one of the established therapies.
国际肝病：对于NAFLD，减轻体重是一个有效的治疗方法。
Hepatology Digest: do you have any specific thoughts for Asians having to do with NAFLD?
国际肝病：对于亚洲人NAFLD您有什么特别需要说一下的吗？
The authors note that NAFLD was the most common cause (81.5%) of hepatic steatosis on ultrasound.
作者认为NAFLD是超声扫描下肝脏脂肪变性最常见的致病因素（81.5%）。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
The study analyzed DNA samples from 236 white female patients with NAFLD confirmed by liver biopsy.
本研究分析了236例经肝活检确证的NAFLD女性患者的DNA样本。
The prevalence of nonalcoholic fatty liver disease(NAFLD)has been increasing gradually year by year.
非乙醇性脂肪肝（ NAFLD）在临床上的发病率呈逐年上升趋势。
In patients with diabetes and NAFLD, could a sufficient insulin dose be used to repair liver fibrosis?
那么请问合并NAFLD的糖尿病患者能否应用足够量的胰岛素治疗来对肝脏纤维化进行修复呢？
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver.
非酒精性脂肪肝被认为是肝的代谢综合症的表现。
This article mainly discusses the relationship of abnormal adipocyte differentiation to IR as well as its effects on NAFLD.
本文主要讨论脂肪细胞分化异常与IR的关系，及其对NAFLD的影响。
Objective To investigate the effects of "Qianggan Capsule" on hepatic lipid in nonalcoholic fatty liver disease (NAFLD) rats.
目的观察强肝胶囊对非酒精性脂肪肝(NAFLD)大鼠模型肝脏脂质的影响。
Hepatology Digest: Although NAFLD is becoming more and more prevalent, it has generally been viewed as a kind of "harmless" disease.
国际肝病：尽管非酒精性脂肪肝越来越常见，但它通常被看做一种“无害”的疾病。
Objetive: To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases (NAFLD).
目的：研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Objective To observe the effect of herbal recipe Zhiganqing capsule (ZGQ capsule) in treating non-alcoholic fatty liver disease (NAFLD).
目的观察脂肝清胶囊对非酒精性脂肪性肝病的疗效。
More and more attentions have been given to the roles of kupffer cell on the pathogenesis of nonalcoholic liver disease (NAFLD) recently.
近年来，国内外学者对其在非酒精性脂肪性肝病(NAFLD)发生机制中的作用给予高度重视。
NAFLD is the most common cause of chronic liver disease and afflicts an estimated 20%-30% of the general population and 67%-75% of the obese population.
非酒精性脂肪肝是慢性肝脏疾病最常见的原因，估计普通人群患病率为20%-30%，肥胖人群患病率为67%-75%。
Future studies should include a randomized controlled trial of exercise training that can reveal its direct effects on NAFLD histopathology, they suggest.
他们建议，未来的研究应该包括运动练习的随机对照试验，以展示它对NAFLD组织病理学的直接作用。
Chronic liver disease has long been associated with long-term alcohol consumption, but as the name suggests, NAFLD is found in those who are not heavy drinkers.
长期以来慢性肝脏疾病与长期饮酒有关，但顾名思义，NAFLD发生在那些不过度饮酒的人中。
This work was conducted as an ancillary study of the NAFLD Clinical research Network, a national research consortium funded by the national Institutes of Health.
这项工作是作为NAFLD临床研究网中一个辅助研究来进行的，该研究网系国立卫生研究院资助的全国研究联盟。
Conclusions Although the patients were young, an OGTT should be recommended for male NAFLD patients with elevated liver enzymes to predict the risk of type 2 diabetes.
结论建议对合并丙氨酸氨基转移酶升高的非酒精性脂肪肝患者，即使是年青病人，亦应行口服糖耐量实验来预测2型糖尿病的危险性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Conclusion: Polyene phosphatidylcholine can improve the adipose metabolism in liver tissue of NAFLD rats. However, it can also increase the glucose level in liver tissue.
结论：多烯磷脂酰胆碱可以促进NAFLD大鼠肝脏所积贮脂肪的分解和转化，但该药也可以使肝糖的水平增加。
应用推荐